Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$178,525
+$6,119 QoQ
Shares Held
493
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,878
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investment Research & Advisory Group, Inc. holds $14,457,073 across 8 Drug Manufacturers - General names. AMGN ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,451 | $8,936,953 | |
| 2 | JNJ |
Johnson & Johnson
|
18,355 | $4,661,619 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,399 | $308,271 | |
| 4 | ABBV |
AbbVie Inc.
|
896 | $225,469 | |
| 5 | AMGN |
Amgen Inc
This page
|
493 | $178,525 | |
| 6 | NVO |
Novo Nordisk A S
|
1,115 | $53,453 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
410 | $51,799 | |
| 8 | PFE |
Pfizer Inc
|
1,702 | $40,984 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $178,525 | 493 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $172,406 | 490 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $168,237 | 514 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $136,867 | 485 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $134,300 | 481 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $214,657 | 689 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $153,516 | 589 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $189,781 | 589 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $188,719 | 604 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $171,729 | 604 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $173,964 | 604 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $162,331 | 604 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $134,100 | 604 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $146,017 | 604 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $158,634 | 604 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $136,141 | 604 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $146,953 | 604 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $146,059 | 604 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $135,881 | 604 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $128,440 | 604 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $147,225 | 604 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $150,281 | 604 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $138,871 | 604 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $153,512 | 604 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $142,459 | 604 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $122,448 | 604 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||